These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32971206)

  • 1. Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection.
    Donlan AN; Simpson ME; Petri WA
    Anaerobe; 2020 Dec; 66():102275. PubMed ID: 32971206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging impairs protective host defenses against Clostridioides (Clostridium) difficile infection in mice by suppressing neutrophil and IL-22 mediated immunity.
    Peniche AG; Spinler JK; Boonma P; Savidge TC; Dann SM
    Anaerobe; 2018 Dec; 54():83-91. PubMed ID: 30099125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
    Wang L; Cao J; Li C; Zhang L
    J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.
    Abernathy-Close L; Dieterle MG; Vendrov KC; Bergin IL; Rao K; Young VB
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32284366
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.
    Buonomo EL; Cowardin CA; Wilson MG; Saleh MM; Pramoonjago P; Petri WA
    Cell Rep; 2016 Jul; 16(2):432-443. PubMed ID: 27346351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).
    Jafari NV; Kuehne SA; Bryant CE; Elawad M; Wren BW; Minton NP; Allan E; Bajaj-Elliott M
    PLoS One; 2013; 8(7):e69846. PubMed ID: 23922820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
    Saleh MM; Petri WA
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31570564
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.
    Cowardin CA; Kuehne SA; Buonomo EL; Marie CS; Minton NP; Petri WA
    mBio; 2015 Jan; 6(1):. PubMed ID: 25626905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.
    Cribas ES; Denny JE; Maslanka JR; Abt MC
    Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.
    Johnston PF; Gerding DN; Knight KL
    Infect Immun; 2014 Feb; 82(2):522-31. PubMed ID: 24478068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin 23 signaling in Clostridium difficile colitis.
    Buonomo EL; Madan R; Pramoonjago P; Li L; Okusa MD; Petri WA
    J Infect Dis; 2013 Sep; 208(6):917-20. PubMed ID: 23776194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.
    Nagao-Kitamoto H; Leslie JL; Kitamoto S; Jin C; Thomsson KA; Gillilland MG; Kuffa P; Goto Y; Jenq RR; Ishii C; Hirayama A; Seekatz AM; Martens EC; Eaton KA; Kao JY; Fukuda S; Higgins PDR; Karlsson NG; Young VB; Kamada N
    Nat Med; 2020 Apr; 26(4):608-617. PubMed ID: 32066975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 15. The Butyrate-Producing Bacterium
    Hayashi A; Nagao-Kitamoto H; Kitamoto S; Kim CH; Kamada N
    J Immunol; 2021 Apr; 206(7):1576-1585. PubMed ID: 33597149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.
    McDermott AJ; Frank CR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
    Gut Microbes; 2014 Jul; 5(4):476-84. PubMed ID: 25045999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.
    Yu H; Chen K; Sun Y; Carter M; Garey KW; Savidge TC; Devaraj S; Tessier ME; von Rosenvinge EC; Kelly CP; Pasetti MF; Feng H
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28592627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptive immune response to Clostridioides difficile: A tricky balance between immunoprotection and immunopathogenesis.
    Hernández Del Pino RE; Barbero AM; Español LÁ; Morro LS; Pasquinelli V
    J Leukoc Biol; 2021 Jan; 109(1):195-210. PubMed ID: 32829520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 20. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.